[go: up one dir, main page]

NO20002218L - Anvendelse av mirtazepin for behandling av søvnapne - Google Patents

Anvendelse av mirtazepin for behandling av søvnapne

Info

Publication number
NO20002218L
NO20002218L NO20002218A NO20002218A NO20002218L NO 20002218 L NO20002218 L NO 20002218L NO 20002218 A NO20002218 A NO 20002218A NO 20002218 A NO20002218 A NO 20002218A NO 20002218 L NO20002218 L NO 20002218L
Authority
NO
Norway
Prior art keywords
mirtazepine
treatment
sleep apnea
mirtazapine
fluoxetin
Prior art date
Application number
NO20002218A
Other languages
English (en)
Other versions
NO20002218D0 (no
Inventor
John Stuart Andrews
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20002218D0 publication Critical patent/NO20002218D0/no
Publication of NO20002218L publication Critical patent/NO20002218L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20002218A 1997-11-14 2000-04-28 Anvendelse av mirtazepin for behandling av søvnapne NO20002218L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203548 1997-11-14
PCT/EP1998/007330 WO1999025356A1 (en) 1997-11-14 1998-11-13 Use of mirtazapine for treating sleep apneas

Publications (2)

Publication Number Publication Date
NO20002218D0 NO20002218D0 (no) 2000-04-28
NO20002218L true NO20002218L (no) 2000-05-12

Family

ID=8228923

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002218A NO20002218L (no) 1997-11-14 2000-04-28 Anvendelse av mirtazepin for behandling av søvnapne

Country Status (20)

Country Link
US (1) US6303595B1 (no)
EP (1) EP1030667B1 (no)
JP (1) JP2001522891A (no)
KR (1) KR20010032009A (no)
CN (1) CN1154495C (no)
AT (1) ATE289816T1 (no)
AU (1) AU737590B2 (no)
BR (1) BR9815098A (no)
CA (1) CA2309744A1 (no)
CZ (1) CZ296282B6 (no)
DE (1) DE69829202T2 (no)
DK (1) DK1030667T3 (no)
ES (1) ES2238781T3 (no)
HU (1) HUP0100080A3 (no)
IL (2) IL135825A0 (no)
NO (1) NO20002218L (no)
PL (1) PL192272B1 (no)
PT (1) PT1030667E (no)
TR (1) TR200001293T2 (no)
WO (1) WO1999025356A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
ATE324110T1 (de) 1998-02-27 2006-05-15 Univ Illinois Stoffe mit serotoninartiger wirkung zur behandlung der schlafapnoe
EP1656937A1 (en) * 2000-02-11 2006-05-17 Akzo Nobel N.V. The use of mirtazapine for the treatment of sleep disorders
US20020183306A1 (en) * 2001-05-30 2002-12-05 Pfizer Inc. Combination treatment for sleep disorders including sleep apnea
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
US7838029B1 (en) 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
ES2426915T3 (es) 2003-09-10 2013-10-25 Brentwood Equities Ltd. Diastereoisómeros de 4-ariloxi-3-hidroxipiperidinas
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
US20060122127A1 (en) * 2004-11-17 2006-06-08 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtzapine treatment
AU2005319367B2 (en) 2004-12-20 2012-05-24 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
WO2008125578A2 (en) 2007-04-11 2008-10-23 N.V. Organon A method for the preparation of mirtazapine
EP2167096A4 (en) * 2007-06-13 2010-07-14 Cypress Bioscience Inc IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM
US10172920B2 (en) 2012-06-14 2019-01-08 The Regents Of The University Of Michigan Sleep apnea treatment
PL3261645T3 (pl) 2015-02-27 2021-12-06 Dechra Limited Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines
PT866711E (pt) * 1995-10-24 2006-12-29 Gruenenthal Gmbh Montirelina para inibição da apneia do sono
SE9504537D0 (sv) 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent

Also Published As

Publication number Publication date
ATE289816T1 (de) 2005-03-15
BR9815098A (pt) 2000-10-10
AU737590B2 (en) 2001-08-23
PL192272B1 (pl) 2006-09-29
US6303595B1 (en) 2001-10-16
CZ20001751A3 (cs) 2000-10-11
PL340467A1 (en) 2001-02-12
JP2001522891A (ja) 2001-11-20
PT1030667E (pt) 2005-06-30
NO20002218D0 (no) 2000-04-28
CA2309744A1 (en) 1999-05-27
CZ296282B6 (cs) 2006-02-15
AU1754899A (en) 1999-06-07
KR20010032009A (ko) 2001-04-16
CN1154495C (zh) 2004-06-23
IL135825A (en) 2006-12-31
EP1030667B1 (en) 2005-03-02
IL135825A0 (en) 2001-05-20
HK1029932A1 (en) 2001-04-20
CN1278731A (zh) 2001-01-03
DE69829202D1 (de) 2005-04-07
DK1030667T3 (da) 2005-06-20
HUP0100080A2 (hu) 2001-08-28
EP1030667A1 (en) 2000-08-30
WO1999025356A1 (en) 1999-05-27
HUP0100080A3 (en) 2002-05-28
DE69829202T2 (de) 2005-07-21
ES2238781T3 (es) 2005-09-01
TR200001293T2 (tr) 2002-09-23

Similar Documents

Publication Publication Date Title
NO20002218D0 (no) Anvendelse av mirtazepin for behandling av søvnapne
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
DE60143906D1 (de) Verwendung von derivaten der 2-oxothiazolidin-4-corbonsäure als prä-abschuppungsmittel
ES2165878T3 (es) Utilizacion del modafinil para el tratamiento de las apneas del sueño y trastornos de ventilacion de origen central.
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
ATE326209T1 (de) Verminderung des haarwuchses
IL163026A (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
EE200200337A (et) Uued ühendid ning nende kasutamine
SE0004101D0 (sv) New use
DK1610864T3 (da) Elektromagnetisk stimulering af patienter med osteoporose
UY26085A1 (es) N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
ATE293972T1 (de) Behandlung von chronischen schmerzen
ZA9711468B (en) New use of comt inhibitors
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
DE602004025683D1 (de) Therapeutische zubereitung für autoimmune erkrankungen
SE9800139D0 (sv) New use
ATE302009T1 (de) Ubichinon qn zur behandlung von migräneschmerzen
ATE302023T1 (de) Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
SE9802207D0 (sv) Novel compounds
EA200501053A1 (ru) Производные 1,2,4-триаминобензола, пригодные для лечения расстройств центральной нервной системы

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application